Thromboseprophylaxe Mit Niedermolekularem Heparin Bei Transurethralen Eingriffen

Trial Profile

Thromboseprophylaxe Mit Niedermolekularem Heparin Bei Transurethralen Eingriffen

Completed
Phase of Trial: Phase III

Latest Information Update: 30 Apr 2009

At a glance

  • Drugs Dalteparin sodium (Primary)
  • Indications Thrombosis
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 30 Apr 2009 Results presented at the American Urological Association Annual Meeting (AUA) 2009.
    • 19 Mar 2009 Results reported at the 24th Annual Congress of the European Association of Urology (EAU), 2009.
    • 12 Jun 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top